Related Experiment Videos
Carbohydrate-deficient glycoprotein syndrome--a fourth subtype
H Stibler1, U Stephani, U Kutsch
1Department of Neurology, Karolinska Hospital, Stockholm, Sweden.
Neuropediatrics
|October 1, 1995
Summary
This study identifies a potential new subtype of carbohydrate-deficient glycoprotein (CDG) syndrome in two infants. The condition presents with microcephaly, severe epilepsy, and distinct glycoprotein abnormalities, differing from known CDG types.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Carbohydrate-deficient glycoprotein (CDG) syndromes are a group of rare inherited metabolic disorders.
- These disorders result from defects in the synthesis of glycans (carbohydrate chains) that are attached to proteins.
- CDG syndromes exhibit a wide range of clinical manifestations, affecting multiple organ systems.
Observation:
- Two infants presented with microcephaly, severe epilepsy, absent psychomotor development, and minor dysmorphic features.
- No signs of liver dysfunction were observed in either patient.
- Analysis of blood glycoproteins revealed abnormal isoforms, indicating a partial deficiency in sialic acid residues.
Findings:
- The observed clinical and biochemical profiles suggest a novel, fourth subtype of CDG syndrome.
- Specific glycoproteins, including transferrin, alpha 1-antitrypsin, antithrombin, and thyroxine-binding globulin, showed abnormal glycosylation patterns.
- The identified abnormalities in sialic acid residues were distinct from those seen in previously characterized CDG types.
Implications:
- This discovery expands the known spectrum of CDG syndromes.
- Further research is needed to elucidate the specific genetic basis and pathophysiology of this potential new subtype.
- Accurate diagnosis and understanding of this subtype are crucial for potential future therapeutic strategies and genetic counseling.